Stay updated on Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to Halodine Nasal Antiseptic in Patients With COVID-19. The change may reflect new information or developments in the study protocol or findings.
    Difference
    0.2%
    Check dated 2024-06-06T14:43:08.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying inclusion and exclusion criteria for participants, such as being hospitalized with COVID-19 and having a positive SARS-CoV-2 test within 48 hours of enrollment, while excluding those with allergies to iodine-containing compounds.
    Difference
    8%
    Check dated 2024-05-22T21:30:21.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T22:35:30.000Z thumbnail image

Stay in the know with updates to Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Halodine Nasal Antiseptic in Patients With COVID-19 Clinical Trial page.